Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects
Clinical trial NCT02112942 · TERMINATED
Trial details
- NCT number
- NCT02112942
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.